PRIME Education (@prime_cme) 's Twitter Profile
PRIME Education

@prime_cme

PRIME is a healthcare education and research company advancing the science of learning and behavior change for 30 years. primece.com

ID: 915998353690955777

linkhttps://primeinc.org calendar_today05-10-2017 17:53:20

3,3K Tweet

397 Followers

1,1K Following

PRIME Education (@prime_cme) 's Twitter Profile Photo

Stay ahead of the curve! | Optimizing Supportive Care and Management in Pediatric Low-Grade Glioma | 0.25-hour CME/CE | Clinical Case Challenge#2 of 2 | #MedEd #cme #Lowgradeglioma | bit.ly/3Xzy8q1

Stay ahead of the curve! | Optimizing Supportive Care and Management in Pediatric Low-Grade Glioma | 0.25-hour CME/CE | Clinical Case Challenge#2 of 2 | #MedEd #cme #Lowgradeglioma | bit.ly/3Xzy8q1
PRIME Education (@prime_cme) 's Twitter Profile Photo

C3 Glomerulopathy: Get a quick update here! | Evaluating the Latest Evidence on Emerging Therapies for C3 Glomerulopathy | 0.25-hour CME/CE | Booster Quiz | #MedEd #cme #C3Glomerulopathy | bit.ly/4jgifgA

C3 Glomerulopathy: Get a quick update here! | Evaluating the Latest Evidence on Emerging Therapies for C3 Glomerulopathy | 0.25-hour CME/CE | Booster Quiz | #MedEd #cme #C3Glomerulopathy | bit.ly/4jgifgA
PRIME Education (@prime_cme) 's Twitter Profile Photo

Sign Up Now for this Live Webinar, June 12th! | Innovating Cancer Care: The Emerging Role of Subcutaneous ICI Therapy | 0.5-hour CME/CE | #MedEd #cme #CancerCare | bit.ly/45c809u

PRIME Education (@prime_cme) 's Twitter Profile Photo

Mitigate TRAEs in Multiple Myeloma Treatment | Best Practices for Monitoring and Managing Adverse Events Associated With Early R/R MM Treatment | 0.25-hour CME/CE | Clinical Case Challenge # 3 of 3 | #MedEd #cme #MultipleMyeloma | bit.ly/3XpWbI3

Mitigate TRAEs in Multiple Myeloma Treatment | Best Practices for Monitoring and Managing Adverse Events Associated With Early R/R MM Treatment | 0.25-hour CME/CE | Clinical Case Challenge # 3 of 3 | #MedEd #cme #MultipleMyeloma | bit.ly/3XpWbI3
PRIME Education (@prime_cme) 's Twitter Profile Photo

Out Now! | Optimizing Treatment of X-Linked Hypophosphatemia: An Interactive Clinical Case Challenge #2 of 2 | 0.25-hour CME/CE | Real-world scenario | Expert feedback | #MedEd #cme #Hypophosphatemia #rarediseasetreatment | bit.ly/3GBlbq3

Out Now! | Optimizing Treatment of X-Linked Hypophosphatemia: An Interactive Clinical Case Challenge #2 of 2 | 0.25-hour CME/CE | Real-world scenario | Expert feedback | #MedEd #cme #Hypophosphatemia #rarediseasetreatment | bit.ly/3GBlbq3
PRIME Education (@prime_cme) 's Twitter Profile Photo

See How You Stack Up! | Evidence-Based Management of Treatment-Related Adverse Events in Pediatric Low-Grade Glioma | 0.5-hour CME/CE | Clinical Case Challenge#1 of 2 | #MedEd #cme #Lowgradeglioma | bit.ly/4ilb3jv

See How You Stack Up! | Evidence-Based Management of Treatment-Related Adverse Events in Pediatric Low-Grade Glioma | 0.5-hour CME/CE | Clinical Case Challenge#1 of 2 | #MedEd #cme #Lowgradeglioma | bit.ly/4ilb3jv
PRIME Education (@prime_cme) 's Twitter Profile Photo

Discover New Horizons in Primary Biliary Cholangitis: Integrating Patient Experiences and Therapeutic Advances to Improve Care | 1-hour CME/CE | Webcast On-Demand | #MedEd #cme #BiliaryCholangitis | bit.ly/42HRrR5

Discover New Horizons in Primary Biliary Cholangitis: Integrating Patient Experiences and Therapeutic Advances to Improve Care | 1-hour CME/CE | Webcast On-Demand
| #MedEd #cme #BiliaryCholangitis | bit.ly/42HRrR5
PRIME Education (@prime_cme) 's Twitter Profile Photo

CMKDs: Timely diagnosis is key | Advancing Early Diagnosis of CMKDs: Expert Approaches and Patient Perspectives | 0.25-hour CME/CE | On-Demand Video | #MedEd #cme #CMKD #rarekidneydisease | bit.ly/3RCp2W0

CMKDs: Timely diagnosis is key | Advancing Early Diagnosis of CMKDs: Expert Approaches and Patient Perspectives | 0.25-hour CME/CE | On-Demand Video | #MedEd #cme #CMKD #rarekidneydisease | bit.ly/3RCp2W0
PRIME Education (@prime_cme) 's Twitter Profile Photo

Register Now for this Live Webinar June 18th! | Multiple Myeloma: Overcome persistent gaps in CAR T-cell care | 0.75-hour CME/CE | #MedEd #cme #MultipleMyeloma | bit.ly/43KQO8A

Register Now for this Live Webinar June 18th! | Multiple Myeloma: Overcome persistent gaps in CAR T-cell care | 0.75-hour CME/CE | #MedEd #cme #MultipleMyeloma |  bit.ly/43KQO8A
PRIME Education (@prime_cme) 's Twitter Profile Photo

CKMDs and complement dysregulation | Harnessing the Alternative Complement Pathway to Improve Outcomes in CMKDs: From Targeted Treatments to Disease Biomarkers | 0.25-hour CME/CE | On-Demand Video | #MedEd #cme #CMKD #rarekidneydisease | bit.ly/3E6FXx6

CKMDs and complement dysregulation | Harnessing the Alternative Complement Pathway to Improve Outcomes in CMKDs: From Targeted Treatments to Disease Biomarkers | 0.25-hour CME/CE | On-Demand Video | #MedEd #cme #CMKD #rarekidneydisease | bit.ly/3E6FXx6
PRIME Education (@prime_cme) 's Twitter Profile Photo

CMKDs: Best practices for DDx | Navigating the Differential Diagnosis of CMKDs: Approaches and Considerations | 0.5-hour CME/CE | On-Demand Video | #MedEd #cme #CMKD #rarekidneydisease | bit.ly/4jbSzlb

CMKDs: Best practices for DDx | Navigating the Differential Diagnosis of CMKDs: Approaches and Considerations | 0.5-hour CME/CE | On-Demand Video | #MedEd #cme #CMKD #rarekidneydisease | bit.ly/4jbSzlb
PRIME Education (@prime_cme) 's Twitter Profile Photo

Register Now for this Live Webinar June 18th! | Multiple Myeloma: Overcome persistent gaps in CAR T-cell care | 0.75-hour CME/CE | #MedEd #cme #MultipleMyeloma | bit.ly/43KQO8A

Register Now for this Live Webinar June 18th! | Multiple Myeloma: Overcome persistent gaps in CAR T-cell care | 0.75-hour CME/CE | #MedEd #cme #MultipleMyeloma |  bit.ly/43KQO8A
PRIME Education (@prime_cme) 's Twitter Profile Photo

Ready to Test Your Expertise? | JAK Inhibitors for Alopecia Areata: A Deep Dive into the Data | 0.25-hour CME/CE | Booster Quiz | #MedEd #cme #JAKInhibitors #AlopeciaAreata | bit.ly/4jC3uo0

Ready to Test Your Expertise? | JAK Inhibitors for Alopecia Areata: A Deep Dive into the Data | 0.25-hour CME/CE | Booster Quiz | #MedEd #cme #JAKInhibitors #AlopeciaAreata | bit.ly/4jC3uo0
PRIME Education (@prime_cme) 's Twitter Profile Photo

CKMD: Novel directed therapeutics | Exploring the New Frontier of CMKD Treatment: The Latest Evidence for New and Emerging Targeted Therapies | 0.75-hour CME/CE | On-Demand Video | #MedEd #cme #CMKDTreatment #rarekidneydisease | bit.ly/4lgOmi5

CKMD: Novel directed therapeutics | Exploring the New Frontier of CMKD Treatment: The Latest Evidence for New and Emerging Targeted Therapies | 0.75-hour CME/CE | On-Demand Video | #MedEd #cme #CMKDTreatment #rarekidneydisease | bit.ly/4lgOmi5
PRIME Education (@prime_cme) 's Twitter Profile Photo

Booster Quiz | Applying the Latest Clinical Evidence to Optimize Outcomes for Patients With Primary Biliary Cholangitis | 0.25-hour CME/CE | Booster Quiz | Part of the SynopsiMedEd™ Interface | #MedEd #cme #Interactivelearning #biliarycholangitis | bit.ly/3HvOOJW

Booster Quiz | Applying the Latest Clinical Evidence to Optimize Outcomes for Patients With Primary Biliary Cholangitis | 0.25-hour CME/CE | Booster Quiz | Part of the SynopsiMedEd™ Interface | #MedEd #cme #Interactivelearning #biliarycholangitis | bit.ly/3HvOOJW
PRIME Education (@prime_cme) 's Twitter Profile Photo

Watch and Download the Resource Now! | Harnessing Biomarker Testing for Evidence-Based Treatment Decision-Making in Advanced G/GEJ Cancers | 0.5-hour CME/CE | On-Demand Video | #MedEd #cme #AdvancedCancerTreatment | bit.ly/3YTR5Vl

Watch and Download the Resource Now! | Harnessing Biomarker Testing for Evidence-Based Treatment Decision-Making in Advanced G/GEJ Cancers | 0.5-hour CME/CE | On-Demand Video | #MedEd #cme #AdvancedCancerTreatment | bit.ly/3YTR5Vl
PRIME Education (@prime_cme) 's Twitter Profile Photo

Watch Now! | Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies from Leading Experts | 1-hour CME/CE | On-Demand Webcast | #MedEd #cme #MyeloidLeukemia | bit.ly/3Z6yeGn

Watch Now! | Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies from Leading Experts | 1-hour CME/CE | On-Demand Webcast | #MedEd #cme #MyeloidLeukemia | bit.ly/3Z6yeGn
PRIME Education (@prime_cme) 's Twitter Profile Photo

Ready to Test Your Expertise? | Recognizing Primary Biliary Cholangitis: Key Symptoms and Diagnostic Strategies | 0.25-hour CME/CE | Clinical Case Challenge #1 of 3 | #MedEd #cme #PrimaryBiliaryCholangitis | bit.ly/43UmqZH

Ready to Test Your Expertise? | Recognizing Primary Biliary Cholangitis: Key Symptoms and Diagnostic Strategies | 0.25-hour CME/CE | Clinical Case Challenge #1 of 3 | #MedEd #cme #PrimaryBiliaryCholangitis | bit.ly/43UmqZH
PRIME Education (@prime_cme) 's Twitter Profile Photo

Catch Up Now! | Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment | 1-hour CME/CE | Enduring Recording of Symposium at SITC 2024 | #MedEd #cme #CancerVaccines #SITC2024 | bit.ly/3RQ3p52

Catch Up Now! | Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment | 1-hour CME/CE | Enduring Recording of Symposium at SITC 2024 | #MedEd #cme #CancerVaccines #SITC2024 | bit.ly/3RQ3p52
PRIME Education (@prime_cme) 's Twitter Profile Photo

Catch Up Now! | Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment | 1-hour CME/CE | Enduring Recording of Symposium at SITC 2024 | #MedEd #cme #CancerVaccines #SITC2024 | bit.ly/3RQ3p52

Catch Up Now! | Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment | 1-hour CME/CE | Enduring Recording of Symposium at SITC 2024 | #MedEd #cme #CancerVaccines #SITC2024 | bit.ly/3RQ3p52